IP Library › Assignment 046033/0403
Patent Assignment
Reel/Frame 046033/0403

Assignment of Assignor's Interest

Recorded: 2018-04-27 Pages: 33
Assignor
CATALYST BIOSCIENCES, INC.
Executed: 2016-10-14
Assignee
OYSTER POINT PHARMA, INC.
700 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NEW JERSEY, 08540
Covered Property (1)
Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 15/962,982 →
Publication: US 2019/0071428
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 27, 2018
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 045661/0119 →
Change of Name Apr 27, 2018
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 046035/0452 →
Patent Security Agreement Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Release of Security Interest Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →